Gail Frances McIntyre, Senior Vice President-Research at Furiex Pharmaceuticals, Inc. (FURX), sold 20,000 shares at $40.00 ($800K) on 2013-07-19, disclosed to the SEC on 2013-07-23.
Scheduled sale ($800k) by Senior Vice President-Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 9,419 | $377K | 47.1% |
| 2 | $40.00 | 10,581 | $423K | 52.9% |
| Total | $40.00 avg | 20,000 | $800K | 100% |
| Filing → |
| FURX | SELL | 2014-06-18 | $7.8M | — | Filing → |
| FURX | SELL | 2014-06-12 | $183K | — | Filing → |
| FURX | SELL | 2013-09-18 | $800K | — | Filing → |